The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
CONCLUSIONS: Vaccination using 4vHPV vaccine has had a large demonstrable impact on HPV-related disease in Australia. A switch to 9vHPV could further reduce the HPV-associated cancer burden. With continued high coverage among both males and females, elimination of vaccine-type HPV disease seems achievable in Australia.
PMID: 30326995 [PubMed - in process]
Source: Euro Surveill - Category: Infectious Diseases Authors: Patel C, Brotherton JM, Pillsbury A, Jayasinghe S, Donovan B, Macartney K, Marshall H Tags: Euro Surveill Source Type: research
More News: Anal Cancer | Australia Health | Boys | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Genital Warts | Girls | Human Papillomavirus (HPV) | Infectious Diseases | Study | Vaccines | Warts | Women